nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLCO1A2—epilepsy syndrome	0.163	0.448	CbGaD
Indinavir—ABCC2—epilepsy syndrome	0.0782	0.214	CbGaD
Indinavir—CYP2C19—epilepsy syndrome	0.0543	0.149	CbGaD
Indinavir—CYP2D6—epilepsy syndrome	0.0403	0.11	CbGaD
Indinavir—ABCB1—epilepsy syndrome	0.0288	0.0788	CbGaD
Indinavir—ABCC2—Levetiracetam—epilepsy syndrome	0.0251	0.0572	CbGbCtD
Indinavir—ABCC1—Phenobarbital—epilepsy syndrome	0.0156	0.0355	CbGbCtD
Indinavir—ABCC2—Carbamazepine—epilepsy syndrome	0.0144	0.0329	CbGbCtD
Indinavir—ABCC2—Phenytoin—epilepsy syndrome	0.0129	0.0295	CbGbCtD
Indinavir—SLC22A1—Midazolam—epilepsy syndrome	0.0121	0.0276	CbGbCtD
Indinavir—ABCC2—Phenobarbital—epilepsy syndrome	0.0115	0.0263	CbGbCtD
Indinavir—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0115	0.0262	CbGbCtD
Indinavir—CYP3A7—Carbamazepine—epilepsy syndrome	0.00963	0.0219	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00963	0.0219	CbGbCtD
Indinavir—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00928	0.0211	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00863	0.0197	CbGbCtD
Indinavir—CYP3A7—Phenytoin—epilepsy syndrome	0.00863	0.0197	CbGbCtD
Indinavir—CYP2C19—Trimethadione—epilepsy syndrome	0.00862	0.0196	CbGbCtD
Indinavir—CYP2C19—Felbamate—epilepsy syndrome	0.00862	0.0196	CbGbCtD
Indinavir—ABCB1—Levetiracetam—epilepsy syndrome	0.00818	0.0186	CbGbCtD
Indinavir—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00811	0.0185	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0077	0.0175	CbGbCtD
Indinavir—CYP3A7—Phenobarbital—epilepsy syndrome	0.0077	0.0175	CbGbCtD
Indinavir—CYP3A7—Midazolam—epilepsy syndrome	0.00759	0.0173	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00759	0.0173	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0073	0.0166	CbGbCtD
Indinavir—CYP3A7—Diazepam—epilepsy syndrome	0.0073	0.0166	CbGbCtD
Indinavir—CYP3A5—Carbamazepine—epilepsy syndrome	0.00722	0.0165	CbGbCtD
Indinavir—CYP2C9—Trimethadione—epilepsy syndrome	0.00717	0.0163	CbGbCtD
Indinavir—CYP2C19—Clobazam—epilepsy syndrome	0.00703	0.016	CbGbCtD
Indinavir—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00674	0.0154	CbGbCtD
Indinavir—CYP3A5—Phenytoin—epilepsy syndrome	0.00648	0.0148	CbGbCtD
Indinavir—CYP2C19—Carbamazepine—epilepsy syndrome	0.00582	0.0133	CbGbCtD
Indinavir—CYP3A5—Phenobarbital—epilepsy syndrome	0.00577	0.0132	CbGbCtD
Indinavir—CYP3A5—Midazolam—epilepsy syndrome	0.00569	0.013	CbGbCtD
Indinavir—ABCB1—Clobazam—epilepsy syndrome	0.00567	0.0129	CbGbCtD
Indinavir—CYP3A5—Diazepam—epilepsy syndrome	0.00547	0.0125	CbGbCtD
Indinavir—ABCB1—Lamotrigine—epilepsy syndrome	0.00546	0.0124	CbGbCtD
Indinavir—CYP2C19—Primidone—epilepsy syndrome	0.00544	0.0124	CbGbCtD
Indinavir—CYP2C19—Phenytoin—epilepsy syndrome	0.00522	0.0119	CbGbCtD
Indinavir—CYP2C19—Propofol—epilepsy syndrome	0.00487	0.0111	CbGbCtD
Indinavir—CYP2C9—Carbamazepine—epilepsy syndrome	0.00484	0.011	CbGbCtD
Indinavir—ABCB1—Carbamazepine—epilepsy syndrome	0.0047	0.0107	CbGbCtD
Indinavir—CYP2C19—Phenobarbital—epilepsy syndrome	0.00466	0.0106	CbGbCtD
Indinavir—CYP2C9—Primidone—epilepsy syndrome	0.00452	0.0103	CbGbCtD
Indinavir—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00448	0.0102	CbGbCtD
Indinavir—CYP2C19—Diazepam—epilepsy syndrome	0.00441	0.0101	CbGbCtD
Indinavir—CYP2C9—Phenytoin—epilepsy syndrome	0.00434	0.0099	CbGbCtD
Indinavir—CYP3A5—Valproic Acid—epilepsy syndrome	0.00431	0.00983	CbGbCtD
Indinavir—CYP2C19—Zonisamide—epilepsy syndrome	0.00431	0.00982	CbGbCtD
Indinavir—ABCB1—Phenytoin—epilepsy syndrome	0.00422	0.00961	CbGbCtD
Indinavir—CYP3A4—Trimethadione—epilepsy syndrome	0.00417	0.0095	CbGbCtD
Indinavir—CYP3A4—Felbamate—epilepsy syndrome	0.00417	0.0095	CbGbCtD
Indinavir—CYP2C9—Propofol—epilepsy syndrome	0.00405	0.00923	CbGbCtD
Indinavir—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00392	0.00893	CbGbCtD
Indinavir—CYP2C9—Phenobarbital—epilepsy syndrome	0.00387	0.00882	CbGbCtD
Indinavir—ABCB1—Phenobarbital—epilepsy syndrome	0.00376	0.00856	CbGbCtD
Indinavir—ABCB1—Midazolam—epilepsy syndrome	0.0037	0.00844	CbGbCtD
Indinavir—CYP2D6—Propofol—epilepsy syndrome	0.0037	0.00844	CbGbCtD
Indinavir—CYP2C9—Diazepam—epilepsy syndrome	0.00367	0.00836	CbGbCtD
Indinavir—ABCB1—Diazepam—epilepsy syndrome	0.00356	0.00812	CbGbCtD
Indinavir—CYP3A4—Clonazepam—epilepsy syndrome	0.00354	0.00808	CbGbCtD
Indinavir—CYP2C19—Valproic Acid—epilepsy syndrome	0.00348	0.00793	CbGbCtD
Indinavir—CYP3A4—Clobazam—epilepsy syndrome	0.0034	0.00774	CbGbCtD
Indinavir—CYP2C19—Topiramate—epilepsy syndrome	0.00314	0.00715	CbGbCtD
Indinavir—CYP2C9—Valproic Acid—epilepsy syndrome	0.00289	0.00659	CbGbCtD
Indinavir—CYP3A4—Rufinamide—epilepsy syndrome	0.00289	0.00658	CbGbCtD
Indinavir—CYP3A4—Carbamazepine—epilepsy syndrome	0.00282	0.00642	CbGbCtD
Indinavir—CYP3A4—Primidone—epilepsy syndrome	0.00263	0.00599	CbGbCtD
Indinavir—CYP3A4—Phenytoin—epilepsy syndrome	0.00253	0.00576	CbGbCtD
Indinavir—CYP3A4—Propofol—epilepsy syndrome	0.00236	0.00537	CbGbCtD
Indinavir—CYP3A4—Phenobarbital—epilepsy syndrome	0.00225	0.00513	CbGbCtD
Indinavir—CYP3A4—Acetazolamide—epilepsy syndrome	0.00225	0.00513	CbGbCtD
Indinavir—CYP3A4—Midazolam—epilepsy syndrome	0.00222	0.00506	CbGbCtD
Indinavir—CYP3A4—Diazepam—epilepsy syndrome	0.00213	0.00486	CbGbCtD
Indinavir—CYP3A4—Zonisamide—epilepsy syndrome	0.00208	0.00475	CbGbCtD
Indinavir—CYP3A4—Valproic Acid—epilepsy syndrome	0.00168	0.00383	CbGbCtD
Indinavir—CYP3A4—Topiramate—epilepsy syndrome	0.00152	0.00346	CbGbCtD
Indinavir—Alvimopan—OPRD1—epilepsy syndrome	0.000588	0.162	CrCbGaD
Indinavir—Nelfinavir—SLCO1A2—epilepsy syndrome	0.000468	0.129	CrCbGaD
Indinavir—Alvimopan—OPRM1—epilepsy syndrome	0.00045	0.124	CrCbGaD
Indinavir—Saquinavir—SLCO1A2—epilepsy syndrome	0.000321	0.0884	CrCbGaD
Indinavir—Saquinavir—CYP11A1—epilepsy syndrome	0.000279	0.077	CrCbGaD
Indinavir—Nelfinavir—ABCG2—epilepsy syndrome	0.000198	0.0546	CrCbGaD
Indinavir—Lopinavir—CYP2C19—epilepsy syndrome	0.000167	0.0461	CrCbGaD
Indinavir—Nelfinavir—CYP2C19—epilepsy syndrome	0.000156	0.0429	CrCbGaD
Indinavir—Saquinavir—ABCC2—epilepsy syndrome	0.000153	0.0423	CrCbGaD
Indinavir—Saquinavir—ABCG2—epilepsy syndrome	0.000136	0.0374	CrCbGaD
Indinavir—Lopinavir—CYP2D6—epilepsy syndrome	0.000124	0.0342	CrCbGaD
Indinavir—Nelfinavir—CYP2D6—epilepsy syndrome	0.000115	0.0318	CrCbGaD
Indinavir—Saquinavir—CYP2C19—epilepsy syndrome	0.000107	0.0294	CrCbGaD
Indinavir—Lopinavir—ABCB1—epilepsy syndrome	8.86e-05	0.0244	CrCbGaD
Indinavir—Nelfinavir—ABCB1—epilepsy syndrome	8.24e-05	0.0227	CrCbGaD
Indinavir—Saquinavir—CYP2D6—epilepsy syndrome	7.91e-05	0.0218	CrCbGaD
Indinavir—Saquinavir—ALB—epilepsy syndrome	5.92e-05	0.0163	CrCbGaD
Indinavir—Saquinavir—ABCB1—epilepsy syndrome	5.65e-05	0.0156	CrCbGaD
Indinavir—Connective tissue disorder—Topiramate—epilepsy syndrome	3.54e-05	0.000248	CcSEcCtD
Indinavir—Nausea—Levetiracetam—epilepsy syndrome	3.54e-05	0.000248	CcSEcCtD
Indinavir—Rash—Vigabatrin—epilepsy syndrome	3.54e-05	0.000248	CcSEcCtD
Indinavir—Dizziness—Felbamate—epilepsy syndrome	3.53e-05	0.000247	CcSEcCtD
Indinavir—Dermatitis—Vigabatrin—epilepsy syndrome	3.53e-05	0.000247	CcSEcCtD
Indinavir—Urethral disorder—Topiramate—epilepsy syndrome	3.53e-05	0.000247	CcSEcCtD
Indinavir—Pruritus—Oxcarbazepine—epilepsy syndrome	3.52e-05	0.000247	CcSEcCtD
Indinavir—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.52e-05	0.000247	CcSEcCtD
Indinavir—Vision blurred—Gabapentin—epilepsy syndrome	3.51e-05	0.000246	CcSEcCtD
Indinavir—Headache—Vigabatrin—epilepsy syndrome	3.51e-05	0.000246	CcSEcCtD
Indinavir—Vomiting—Diazepam—epilepsy syndrome	3.51e-05	0.000246	CcSEcCtD
Indinavir—Anorexia—Valproic Acid—epilepsy syndrome	3.5e-05	0.000245	CcSEcCtD
Indinavir—Tremor—Gabapentin—epilepsy syndrome	3.49e-05	0.000245	CcSEcCtD
Indinavir—Rash—Diazepam—epilepsy syndrome	3.48e-05	0.000244	CcSEcCtD
Indinavir—Dermatitis—Diazepam—epilepsy syndrome	3.48e-05	0.000243	CcSEcCtD
Indinavir—Arthralgia—Pregabalin—epilepsy syndrome	3.46e-05	0.000242	CcSEcCtD
Indinavir—Myalgia—Pregabalin—epilepsy syndrome	3.46e-05	0.000242	CcSEcCtD
Indinavir—Chest pain—Pregabalin—epilepsy syndrome	3.46e-05	0.000242	CcSEcCtD
Indinavir—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.46e-05	0.000242	CcSEcCtD
Indinavir—Dizziness—Zonisamide—epilepsy syndrome	3.46e-05	0.000242	CcSEcCtD
Indinavir—Headache—Diazepam—epilepsy syndrome	3.46e-05	0.000242	CcSEcCtD
Indinavir—Anxiety—Pregabalin—epilepsy syndrome	3.45e-05	0.000242	CcSEcCtD
Indinavir—Diarrhoea—Clonazepam—epilepsy syndrome	3.45e-05	0.000241	CcSEcCtD
Indinavir—Anaemia—Gabapentin—epilepsy syndrome	3.45e-05	0.000241	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.44e-05	0.000241	CcSEcCtD
Indinavir—Asthenia—Carbamazepine—epilepsy syndrome	3.43e-05	0.00024	CcSEcCtD
Indinavir—Agitation—Gabapentin—epilepsy syndrome	3.43e-05	0.00024	CcSEcCtD
Indinavir—Diarrhoea—Phenytoin—epilepsy syndrome	3.43e-05	0.00024	CcSEcCtD
Indinavir—Discomfort—Pregabalin—epilepsy syndrome	3.42e-05	0.000239	CcSEcCtD
Indinavir—Nausea—Fosphenytoin—epilepsy syndrome	3.42e-05	0.000239	CcSEcCtD
Indinavir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.41e-05	0.000239	CcSEcCtD
Indinavir—Erythema multiforme—Topiramate—epilepsy syndrome	3.41e-05	0.000239	CcSEcCtD
Indinavir—Angioedema—Gabapentin—epilepsy syndrome	3.41e-05	0.000239	CcSEcCtD
Indinavir—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.4e-05	0.000238	CcSEcCtD
Indinavir—Vomiting—Felbamate—epilepsy syndrome	3.4e-05	0.000238	CcSEcCtD
Indinavir—Dry mouth—Pregabalin—epilepsy syndrome	3.39e-05	0.000237	CcSEcCtD
Indinavir—Pruritus—Carbamazepine—epilepsy syndrome	3.38e-05	0.000237	CcSEcCtD
Indinavir—Rash—Felbamate—epilepsy syndrome	3.37e-05	0.000236	CcSEcCtD
Indinavir—Dermatitis—Felbamate—epilepsy syndrome	3.37e-05	0.000236	CcSEcCtD
Indinavir—Malaise—Gabapentin—epilepsy syndrome	3.36e-05	0.000235	CcSEcCtD
Indinavir—Vertigo—Gabapentin—epilepsy syndrome	3.35e-05	0.000235	CcSEcCtD
Indinavir—Headache—Felbamate—epilepsy syndrome	3.35e-05	0.000234	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.34e-05	0.000234	CcSEcCtD
Indinavir—Flushing—Topiramate—epilepsy syndrome	3.34e-05	0.000234	CcSEcCtD
Indinavir—Syncope—Gabapentin—epilepsy syndrome	3.34e-05	0.000234	CcSEcCtD
Indinavir—Dizziness—Clonazepam—epilepsy syndrome	3.33e-05	0.000233	CcSEcCtD
Indinavir—Nausea—Vigabatrin—epilepsy syndrome	3.33e-05	0.000233	CcSEcCtD
Indinavir—Vomiting—Zonisamide—epilepsy syndrome	3.33e-05	0.000233	CcSEcCtD
Indinavir—Insomnia—Valproic Acid—epilepsy syndrome	3.32e-05	0.000232	CcSEcCtD
Indinavir—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.32e-05	0.000232	CcSEcCtD
Indinavir—Oedema—Pregabalin—epilepsy syndrome	3.32e-05	0.000232	CcSEcCtD
Indinavir—Asthenia—Lamotrigine—epilepsy syndrome	3.31e-05	0.000232	CcSEcCtD
Indinavir—Dizziness—Phenytoin—epilepsy syndrome	3.31e-05	0.000232	CcSEcCtD
Indinavir—Rash—Zonisamide—epilepsy syndrome	3.3e-05	0.000231	CcSEcCtD
Indinavir—Paraesthesia—Valproic Acid—epilepsy syndrome	3.3e-05	0.000231	CcSEcCtD
Indinavir—Palpitations—Gabapentin—epilepsy syndrome	3.3e-05	0.000231	CcSEcCtD
Indinavir—Dermatitis—Zonisamide—epilepsy syndrome	3.3e-05	0.000231	CcSEcCtD
Indinavir—Dizziness—Oxcarbazepine—epilepsy syndrome	3.29e-05	0.000231	CcSEcCtD
Indinavir—Nausea—Diazepam—epilepsy syndrome	3.28e-05	0.00023	CcSEcCtD
Indinavir—Loss of consciousness—Gabapentin—epilepsy syndrome	3.28e-05	0.000229	CcSEcCtD
Indinavir—Headache—Zonisamide—epilepsy syndrome	3.28e-05	0.000229	CcSEcCtD
Indinavir—Dyspnoea—Valproic Acid—epilepsy syndrome	3.27e-05	0.000229	CcSEcCtD
Indinavir—Diarrhoea—Carbamazepine—epilepsy syndrome	3.27e-05	0.000229	CcSEcCtD
Indinavir—Pruritus—Lamotrigine—epilepsy syndrome	3.27e-05	0.000229	CcSEcCtD
Indinavir—Shock—Pregabalin—epilepsy syndrome	3.27e-05	0.000229	CcSEcCtD
Indinavir—Somnolence—Valproic Acid—epilepsy syndrome	3.26e-05	0.000228	CcSEcCtD
Indinavir—Immune system disorder—Topiramate—epilepsy syndrome	3.26e-05	0.000228	CcSEcCtD
Indinavir—Nervous system disorder—Pregabalin—epilepsy syndrome	3.25e-05	0.000228	CcSEcCtD
Indinavir—Cough—Gabapentin—epilepsy syndrome	3.25e-05	0.000228	CcSEcCtD
Indinavir—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.25e-05	0.000227	CcSEcCtD
Indinavir—Chills—Topiramate—epilepsy syndrome	3.23e-05	0.000226	CcSEcCtD
Indinavir—Dyspepsia—Valproic Acid—epilepsy syndrome	3.23e-05	0.000226	CcSEcCtD
Indinavir—Skin disorder—Pregabalin—epilepsy syndrome	3.22e-05	0.000226	CcSEcCtD
Indinavir—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.21e-05	0.000225	CcSEcCtD
Indinavir—Vomiting—Clonazepam—epilepsy syndrome	3.21e-05	0.000224	CcSEcCtD
Indinavir—Decreased appetite—Valproic Acid—epilepsy syndrome	3.19e-05	0.000223	CcSEcCtD
Indinavir—Alopecia—Topiramate—epilepsy syndrome	3.18e-05	0.000223	CcSEcCtD
Indinavir—Vomiting—Phenytoin—epilepsy syndrome	3.18e-05	0.000223	CcSEcCtD
Indinavir—Rash—Clonazepam—epilepsy syndrome	3.18e-05	0.000223	CcSEcCtD
Indinavir—Dermatitis—Clonazepam—epilepsy syndrome	3.18e-05	0.000222	CcSEcCtD
Indinavir—Chest pain—Gabapentin—epilepsy syndrome	3.17e-05	0.000222	CcSEcCtD
Indinavir—Myalgia—Gabapentin—epilepsy syndrome	3.17e-05	0.000222	CcSEcCtD
Indinavir—Arthralgia—Gabapentin—epilepsy syndrome	3.17e-05	0.000222	CcSEcCtD
Indinavir—Nausea—Felbamate—epilepsy syndrome	3.17e-05	0.000222	CcSEcCtD
Indinavir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.17e-05	0.000222	CcSEcCtD
Indinavir—Vomiting—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.000222	CcSEcCtD
Indinavir—Fatigue—Valproic Acid—epilepsy syndrome	3.17e-05	0.000222	CcSEcCtD
Indinavir—Anxiety—Gabapentin—epilepsy syndrome	3.16e-05	0.000221	CcSEcCtD
Indinavir—Anorexia—Pregabalin—epilepsy syndrome	3.16e-05	0.000221	CcSEcCtD
Indinavir—Dizziness—Carbamazepine—epilepsy syndrome	3.16e-05	0.000221	CcSEcCtD
Indinavir—Diarrhoea—Lamotrigine—epilepsy syndrome	3.16e-05	0.000221	CcSEcCtD
Indinavir—Headache—Clonazepam—epilepsy syndrome	3.16e-05	0.000221	CcSEcCtD
Indinavir—Rash—Phenytoin—epilepsy syndrome	3.16e-05	0.000221	CcSEcCtD
Indinavir—Dermatitis—Phenytoin—epilepsy syndrome	3.15e-05	0.000221	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.15e-05	0.000221	CcSEcCtD
Indinavir—Rash—Oxcarbazepine—epilepsy syndrome	3.14e-05	0.00022	CcSEcCtD
Indinavir—Constipation—Valproic Acid—epilepsy syndrome	3.14e-05	0.00022	CcSEcCtD
Indinavir—Pain—Valproic Acid—epilepsy syndrome	3.14e-05	0.00022	CcSEcCtD
Indinavir—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.14e-05	0.00022	CcSEcCtD
Indinavir—Headache—Phenytoin—epilepsy syndrome	3.14e-05	0.00022	CcSEcCtD
Indinavir—Malnutrition—Topiramate—epilepsy syndrome	3.14e-05	0.00022	CcSEcCtD
Indinavir—Discomfort—Gabapentin—epilepsy syndrome	3.14e-05	0.00022	CcSEcCtD
Indinavir—Headache—Oxcarbazepine—epilepsy syndrome	3.12e-05	0.000218	CcSEcCtD
Indinavir—Nausea—Zonisamide—epilepsy syndrome	3.11e-05	0.000218	CcSEcCtD
Indinavir—Dry mouth—Gabapentin—epilepsy syndrome	3.1e-05	0.000217	CcSEcCtD
Indinavir—Flatulence—Topiramate—epilepsy syndrome	3.09e-05	0.000216	CcSEcCtD
Indinavir—Tension—Topiramate—epilepsy syndrome	3.08e-05	0.000216	CcSEcCtD
Indinavir—Dysgeusia—Topiramate—epilepsy syndrome	3.07e-05	0.000215	CcSEcCtD
Indinavir—Dizziness—Lamotrigine—epilepsy syndrome	3.06e-05	0.000214	CcSEcCtD
Indinavir—Nervousness—Topiramate—epilepsy syndrome	3.05e-05	0.000213	CcSEcCtD
Indinavir—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.04e-05	0.000213	CcSEcCtD
Indinavir—Oedema—Gabapentin—epilepsy syndrome	3.04e-05	0.000213	CcSEcCtD
Indinavir—Vomiting—Carbamazepine—epilepsy syndrome	3.04e-05	0.000213	CcSEcCtD
Indinavir—Back pain—Topiramate—epilepsy syndrome	3.03e-05	0.000212	CcSEcCtD
Indinavir—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.03e-05	0.000212	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.02e-05	0.000212	CcSEcCtD
Indinavir—Muscle spasms—Topiramate—epilepsy syndrome	3.02e-05	0.000211	CcSEcCtD
Indinavir—Rash—Carbamazepine—epilepsy syndrome	3.01e-05	0.000211	CcSEcCtD
Indinavir—Dermatitis—Carbamazepine—epilepsy syndrome	3.01e-05	0.000211	CcSEcCtD
Indinavir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3e-05	0.00021	CcSEcCtD
Indinavir—Insomnia—Pregabalin—epilepsy syndrome	3e-05	0.00021	CcSEcCtD
Indinavir—Nausea—Clonazepam—epilepsy syndrome	2.99e-05	0.00021	CcSEcCtD
Indinavir—Headache—Carbamazepine—epilepsy syndrome	2.99e-05	0.00021	CcSEcCtD
Indinavir—Shock—Gabapentin—epilepsy syndrome	2.99e-05	0.00021	CcSEcCtD
Indinavir—Nervous system disorder—Gabapentin—epilepsy syndrome	2.98e-05	0.000209	CcSEcCtD
Indinavir—Paraesthesia—Pregabalin—epilepsy syndrome	2.98e-05	0.000209	CcSEcCtD
Indinavir—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.98e-05	0.000209	CcSEcCtD
Indinavir—Nausea—Phenytoin—epilepsy syndrome	2.97e-05	0.000208	CcSEcCtD
Indinavir—Dyspnoea—Pregabalin—epilepsy syndrome	2.96e-05	0.000207	CcSEcCtD
Indinavir—Nausea—Oxcarbazepine—epilepsy syndrome	2.96e-05	0.000207	CcSEcCtD
Indinavir—Vision blurred—Topiramate—epilepsy syndrome	2.96e-05	0.000207	CcSEcCtD
Indinavir—Skin disorder—Gabapentin—epilepsy syndrome	2.96e-05	0.000207	CcSEcCtD
Indinavir—Somnolence—Pregabalin—epilepsy syndrome	2.95e-05	0.000207	CcSEcCtD
Indinavir—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.94e-05	0.000206	CcSEcCtD
Indinavir—Tremor—Topiramate—epilepsy syndrome	2.94e-05	0.000206	CcSEcCtD
Indinavir—Vomiting—Lamotrigine—epilepsy syndrome	2.94e-05	0.000206	CcSEcCtD
Indinavir—Urticaria—Valproic Acid—epilepsy syndrome	2.92e-05	0.000204	CcSEcCtD
Indinavir—Rash—Lamotrigine—epilepsy syndrome	2.91e-05	0.000204	CcSEcCtD
Indinavir—Ill-defined disorder—Topiramate—epilepsy syndrome	2.91e-05	0.000204	CcSEcCtD
Indinavir—Dermatitis—Lamotrigine—epilepsy syndrome	2.91e-05	0.000204	CcSEcCtD
Indinavir—Abdominal pain—Valproic Acid—epilepsy syndrome	2.9e-05	0.000203	CcSEcCtD
Indinavir—Body temperature increased—Valproic Acid—epilepsy syndrome	2.9e-05	0.000203	CcSEcCtD
Indinavir—Anorexia—Gabapentin—epilepsy syndrome	2.9e-05	0.000203	CcSEcCtD
Indinavir—Anaemia—Topiramate—epilepsy syndrome	2.9e-05	0.000203	CcSEcCtD
Indinavir—Headache—Lamotrigine—epilepsy syndrome	2.89e-05	0.000203	CcSEcCtD
Indinavir—Decreased appetite—Pregabalin—epilepsy syndrome	2.89e-05	0.000202	CcSEcCtD
Indinavir—Agitation—Topiramate—epilepsy syndrome	2.88e-05	0.000202	CcSEcCtD
Indinavir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.87e-05	0.000201	CcSEcCtD
Indinavir—Fatigue—Pregabalin—epilepsy syndrome	2.86e-05	0.0002	CcSEcCtD
Indinavir—Nausea—Carbamazepine—epilepsy syndrome	2.84e-05	0.000199	CcSEcCtD
Indinavir—Pain—Pregabalin—epilepsy syndrome	2.84e-05	0.000199	CcSEcCtD
Indinavir—Constipation—Pregabalin—epilepsy syndrome	2.84e-05	0.000199	CcSEcCtD
Indinavir—Malaise—Topiramate—epilepsy syndrome	2.83e-05	0.000198	CcSEcCtD
Indinavir—Vertigo—Topiramate—epilepsy syndrome	2.82e-05	0.000197	CcSEcCtD
Indinavir—Syncope—Topiramate—epilepsy syndrome	2.81e-05	0.000197	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.77e-05	0.000194	CcSEcCtD
Indinavir—Palpitations—Topiramate—epilepsy syndrome	2.77e-05	0.000194	CcSEcCtD
Indinavir—Loss of consciousness—Topiramate—epilepsy syndrome	2.76e-05	0.000193	CcSEcCtD
Indinavir—Insomnia—Gabapentin—epilepsy syndrome	2.75e-05	0.000193	CcSEcCtD
Indinavir—Nausea—Lamotrigine—epilepsy syndrome	2.74e-05	0.000192	CcSEcCtD
Indinavir—Cough—Topiramate—epilepsy syndrome	2.74e-05	0.000192	CcSEcCtD
Indinavir—Feeling abnormal—Pregabalin—epilepsy syndrome	2.73e-05	0.000191	CcSEcCtD
Indinavir—Paraesthesia—Gabapentin—epilepsy syndrome	2.73e-05	0.000191	CcSEcCtD
Indinavir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.71e-05	0.00019	CcSEcCtD
Indinavir—Dyspnoea—Gabapentin—epilepsy syndrome	2.71e-05	0.00019	CcSEcCtD
Indinavir—Somnolence—Gabapentin—epilepsy syndrome	2.71e-05	0.000189	CcSEcCtD
Indinavir—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.7e-05	0.000189	CcSEcCtD
Indinavir—Dyspepsia—Gabapentin—epilepsy syndrome	2.68e-05	0.000188	CcSEcCtD
Indinavir—Myalgia—Topiramate—epilepsy syndrome	2.67e-05	0.000187	CcSEcCtD
Indinavir—Chest pain—Topiramate—epilepsy syndrome	2.67e-05	0.000187	CcSEcCtD
Indinavir—Arthralgia—Topiramate—epilepsy syndrome	2.67e-05	0.000187	CcSEcCtD
Indinavir—Anxiety—Topiramate—epilepsy syndrome	2.66e-05	0.000186	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.65e-05	0.000186	CcSEcCtD
Indinavir—Decreased appetite—Gabapentin—epilepsy syndrome	2.65e-05	0.000185	CcSEcCtD
Indinavir—Discomfort—Topiramate—epilepsy syndrome	2.64e-05	0.000185	CcSEcCtD
Indinavir—Urticaria—Pregabalin—epilepsy syndrome	2.64e-05	0.000185	CcSEcCtD
Indinavir—Asthenia—Valproic Acid—epilepsy syndrome	2.63e-05	0.000184	CcSEcCtD
Indinavir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.63e-05	0.000184	CcSEcCtD
Indinavir—Fatigue—Gabapentin—epilepsy syndrome	2.62e-05	0.000184	CcSEcCtD
Indinavir—Abdominal pain—Pregabalin—epilepsy syndrome	2.62e-05	0.000184	CcSEcCtD
Indinavir—Body temperature increased—Pregabalin—epilepsy syndrome	2.62e-05	0.000184	CcSEcCtD
Indinavir—Dry mouth—Topiramate—epilepsy syndrome	2.61e-05	0.000183	CcSEcCtD
Indinavir—Pain—Gabapentin—epilepsy syndrome	2.6e-05	0.000182	CcSEcCtD
Indinavir—Constipation—Gabapentin—epilepsy syndrome	2.6e-05	0.000182	CcSEcCtD
Indinavir—Pruritus—Valproic Acid—epilepsy syndrome	2.6e-05	0.000182	CcSEcCtD
Indinavir—Oedema—Topiramate—epilepsy syndrome	2.56e-05	0.000179	CcSEcCtD
Indinavir—Shock—Topiramate—epilepsy syndrome	2.52e-05	0.000176	CcSEcCtD
Indinavir—Diarrhoea—Valproic Acid—epilepsy syndrome	2.51e-05	0.000176	CcSEcCtD
Indinavir—Nervous system disorder—Topiramate—epilepsy syndrome	2.51e-05	0.000176	CcSEcCtD
Indinavir—Feeling abnormal—Gabapentin—epilepsy syndrome	2.51e-05	0.000176	CcSEcCtD
Indinavir—Thrombocytopenia—Topiramate—epilepsy syndrome	2.51e-05	0.000175	CcSEcCtD
Indinavir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.49e-05	0.000174	CcSEcCtD
Indinavir—Skin disorder—Topiramate—epilepsy syndrome	2.49e-05	0.000174	CcSEcCtD
Indinavir—Hyperhidrosis—Topiramate—epilepsy syndrome	2.48e-05	0.000173	CcSEcCtD
Indinavir—Hypersensitivity—Pregabalin—epilepsy syndrome	2.45e-05	0.000171	CcSEcCtD
Indinavir—Anorexia—Topiramate—epilepsy syndrome	2.44e-05	0.000171	CcSEcCtD
Indinavir—Dizziness—Valproic Acid—epilepsy syndrome	2.43e-05	0.00017	CcSEcCtD
Indinavir—Urticaria—Gabapentin—epilepsy syndrome	2.42e-05	0.000169	CcSEcCtD
Indinavir—Body temperature increased—Gabapentin—epilepsy syndrome	2.41e-05	0.000168	CcSEcCtD
Indinavir—Abdominal pain—Gabapentin—epilepsy syndrome	2.41e-05	0.000168	CcSEcCtD
Indinavir—Asthenia—Pregabalin—epilepsy syndrome	2.38e-05	0.000167	CcSEcCtD
Indinavir—Pruritus—Pregabalin—epilepsy syndrome	2.35e-05	0.000164	CcSEcCtD
Indinavir—Vomiting—Valproic Acid—epilepsy syndrome	2.33e-05	0.000163	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.33e-05	0.000163	CcSEcCtD
Indinavir—Insomnia—Topiramate—epilepsy syndrome	2.32e-05	0.000162	CcSEcCtD
Indinavir—Rash—Valproic Acid—epilepsy syndrome	2.31e-05	0.000162	CcSEcCtD
Indinavir—Dermatitis—Valproic Acid—epilepsy syndrome	2.31e-05	0.000162	CcSEcCtD
Indinavir—Headache—Valproic Acid—epilepsy syndrome	2.3e-05	0.000161	CcSEcCtD
Indinavir—Paraesthesia—Topiramate—epilepsy syndrome	2.3e-05	0.000161	CcSEcCtD
Indinavir—Dyspnoea—Topiramate—epilepsy syndrome	2.28e-05	0.00016	CcSEcCtD
Indinavir—Somnolence—Topiramate—epilepsy syndrome	2.28e-05	0.000159	CcSEcCtD
Indinavir—Diarrhoea—Pregabalin—epilepsy syndrome	2.27e-05	0.000159	CcSEcCtD
Indinavir—Dyspepsia—Topiramate—epilepsy syndrome	2.25e-05	0.000158	CcSEcCtD
Indinavir—Hypersensitivity—Gabapentin—epilepsy syndrome	2.24e-05	0.000157	CcSEcCtD
Indinavir—Decreased appetite—Topiramate—epilepsy syndrome	2.23e-05	0.000156	CcSEcCtD
Indinavir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.21e-05	0.000155	CcSEcCtD
Indinavir—Fatigue—Topiramate—epilepsy syndrome	2.21e-05	0.000155	CcSEcCtD
Indinavir—Dizziness—Pregabalin—epilepsy syndrome	2.19e-05	0.000154	CcSEcCtD
Indinavir—Constipation—Topiramate—epilepsy syndrome	2.19e-05	0.000153	CcSEcCtD
Indinavir—Pain—Topiramate—epilepsy syndrome	2.19e-05	0.000153	CcSEcCtD
Indinavir—Asthenia—Gabapentin—epilepsy syndrome	2.18e-05	0.000153	CcSEcCtD
Indinavir—Nausea—Valproic Acid—epilepsy syndrome	2.18e-05	0.000153	CcSEcCtD
Indinavir—Pruritus—Gabapentin—epilepsy syndrome	2.15e-05	0.000151	CcSEcCtD
Indinavir—Vomiting—Pregabalin—epilepsy syndrome	2.11e-05	0.000148	CcSEcCtD
Indinavir—Feeling abnormal—Topiramate—epilepsy syndrome	2.11e-05	0.000148	CcSEcCtD
Indinavir—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.09e-05	0.000147	CcSEcCtD
Indinavir—Rash—Pregabalin—epilepsy syndrome	2.09e-05	0.000146	CcSEcCtD
Indinavir—Dermatitis—Pregabalin—epilepsy syndrome	2.09e-05	0.000146	CcSEcCtD
Indinavir—Diarrhoea—Gabapentin—epilepsy syndrome	2.08e-05	0.000146	CcSEcCtD
Indinavir—Headache—Pregabalin—epilepsy syndrome	2.08e-05	0.000146	CcSEcCtD
Indinavir—Urticaria—Topiramate—epilepsy syndrome	2.03e-05	0.000142	CcSEcCtD
Indinavir—Body temperature increased—Topiramate—epilepsy syndrome	2.02e-05	0.000142	CcSEcCtD
Indinavir—Abdominal pain—Topiramate—epilepsy syndrome	2.02e-05	0.000142	CcSEcCtD
Indinavir—Dizziness—Gabapentin—epilepsy syndrome	2.01e-05	0.000141	CcSEcCtD
Indinavir—Nausea—Pregabalin—epilepsy syndrome	1.97e-05	0.000138	CcSEcCtD
Indinavir—Vomiting—Gabapentin—epilepsy syndrome	1.94e-05	0.000135	CcSEcCtD
Indinavir—Rash—Gabapentin—epilepsy syndrome	1.92e-05	0.000134	CcSEcCtD
Indinavir—Dermatitis—Gabapentin—epilepsy syndrome	1.92e-05	0.000134	CcSEcCtD
Indinavir—Headache—Gabapentin—epilepsy syndrome	1.91e-05	0.000133	CcSEcCtD
Indinavir—Hypersensitivity—Topiramate—epilepsy syndrome	1.89e-05	0.000132	CcSEcCtD
Indinavir—Asthenia—Topiramate—epilepsy syndrome	1.84e-05	0.000129	CcSEcCtD
Indinavir—Pruritus—Topiramate—epilepsy syndrome	1.81e-05	0.000127	CcSEcCtD
Indinavir—Nausea—Gabapentin—epilepsy syndrome	1.81e-05	0.000127	CcSEcCtD
Indinavir—Diarrhoea—Topiramate—epilepsy syndrome	1.75e-05	0.000123	CcSEcCtD
Indinavir—Dizziness—Topiramate—epilepsy syndrome	1.69e-05	0.000119	CcSEcCtD
Indinavir—Vomiting—Topiramate—epilepsy syndrome	1.63e-05	0.000114	CcSEcCtD
Indinavir—Rash—Topiramate—epilepsy syndrome	1.61e-05	0.000113	CcSEcCtD
Indinavir—Dermatitis—Topiramate—epilepsy syndrome	1.61e-05	0.000113	CcSEcCtD
Indinavir—Headache—Topiramate—epilepsy syndrome	1.6e-05	0.000112	CcSEcCtD
Indinavir—Nausea—Topiramate—epilepsy syndrome	1.52e-05	0.000106	CcSEcCtD
Indinavir—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	5.05e-06	0.000101	CbGpPWpGaD
Indinavir—ABCC1—Disease—FYN—epilepsy syndrome	5.04e-06	0.000101	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.03e-06	0.000101	CbGpPWpGaD
Indinavir—ABCC1—Disease—H2AFX—epilepsy syndrome	5.02e-06	0.000101	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	5.01e-06	0.000101	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ADSL—epilepsy syndrome	4.96e-06	9.95e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ABCB1—epilepsy syndrome	4.94e-06	9.92e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.93e-06	9.9e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ADSL—epilepsy syndrome	4.91e-06	9.87e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	4.91e-06	9.86e-05	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.9e-06	9.85e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GLUL—epilepsy syndrome	4.86e-06	9.76e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	4.86e-06	9.75e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	4.85e-06	9.74e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—YWHAZ—epilepsy syndrome	4.85e-06	9.73e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—TH—epilepsy syndrome	4.84e-06	9.72e-05	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.82e-06	9.68e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.82e-06	9.67e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	4.81e-06	9.66e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—BCHE—epilepsy syndrome	4.79e-06	9.62e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	4.77e-06	9.58e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.74e-06	9.51e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.73e-06	9.5e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AQP1—epilepsy syndrome	4.71e-06	9.46e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.7e-06	9.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.67e-06	9.39e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.67e-06	9.39e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.67e-06	9.39e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.67e-06	9.39e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.67e-06	9.39e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.66e-06	9.36e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CCR5—epilepsy syndrome	4.66e-06	9.36e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—HMOX1—epilepsy syndrome	4.63e-06	9.3e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.6e-06	9.23e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	4.59e-06	9.22e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	4.57e-06	9.18e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CAT—epilepsy syndrome	4.57e-06	9.18e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.52e-06	9.08e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	4.52e-06	9.08e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—TH—epilepsy syndrome	4.5e-06	9.05e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	4.49e-06	9.02e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	4.46e-06	8.96e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ABCB1—epilepsy syndrome	4.45e-06	8.93e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.42e-06	8.88e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	4.4e-06	8.84e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	4.38e-06	8.79e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	4.35e-06	8.73e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CAT—epilepsy syndrome	4.34e-06	8.72e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—TSC2—epilepsy syndrome	4.33e-06	8.7e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.33e-06	8.7e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.29e-06	8.62e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.28e-06	8.59e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.28e-06	8.59e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.28e-06	8.59e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.26e-06	8.55e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.26e-06	8.55e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—APOE—epilepsy syndrome	4.24e-06	8.51e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	4.22e-06	8.48e-05	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.2e-06	8.44e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.16e-06	8.35e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.16e-06	8.35e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GPX1—epilepsy syndrome	4.13e-06	8.3e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.12e-06	8.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.12e-06	8.26e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	4.04e-06	8.11e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AGT—epilepsy syndrome	4.03e-06	8.09e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CAT—epilepsy syndrome	3.99e-06	8e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6ST—epilepsy syndrome	3.98e-06	8e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.97e-06	7.98e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.97e-06	7.98e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.97e-06	7.96e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—NOS2—epilepsy syndrome	3.95e-06	7.93e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—APOE—epilepsy syndrome	3.95e-06	7.92e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	3.93e-06	7.89e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.93e-06	7.88e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.92e-06	7.87e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.92e-06	7.87e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.89e-06	7.8e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.88e-06	7.8e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.88e-06	7.8e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	3.88e-06	7.79e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	3.76e-06	7.55e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.74e-06	7.5e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.74e-06	7.5e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.72e-06	7.47e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CAT—epilepsy syndrome	3.71e-06	7.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.64e-06	7.3e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AGT—epilepsy syndrome	3.62e-06	7.28e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.62e-06	7.26e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	3.61e-06	7.25e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GPX1—epilepsy syndrome	3.6e-06	7.24e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—APOE—epilepsy syndrome	3.55e-06	7.13e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	3.55e-06	7.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.54e-06	7.12e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.54e-06	7.11e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.54e-06	7.11e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	3.51e-06	7.05e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—TH—epilepsy syndrome	3.5e-06	7.03e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.47e-06	6.97e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AGT—epilepsy syndrome	3.44e-06	6.92e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—POMC—epilepsy syndrome	3.39e-06	6.81e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.39e-06	6.8e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.38e-06	6.79e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.38e-06	6.79e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—APOE—epilepsy syndrome	3.37e-06	6.78e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.36e-06	6.75e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GPX1—epilepsy syndrome	3.35e-06	6.74e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.34e-06	6.7e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.31e-06	6.64e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.3e-06	6.63e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.28e-06	6.59e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.24e-06	6.51e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—FGF2—epilepsy syndrome	3.22e-06	6.47e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.19e-06	6.41e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.18e-06	6.38e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.17e-06	6.36e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AGT—epilepsy syndrome	3.16e-06	6.35e-05	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.13e-06	6.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.12e-06	6.26e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.11e-06	6.25e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—APOE—epilepsy syndrome	3.1e-06	6.22e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.09e-06	6.21e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALB—epilepsy syndrome	3.09e-06	6.21e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.09e-06	6.2e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.07e-06	6.16e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—POMC—epilepsy syndrome	3.05e-06	6.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.04e-06	6.11e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.04e-06	6.11e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.03e-06	6.09e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.96e-06	5.95e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AGT—epilepsy syndrome	2.94e-06	5.91e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MTOR—epilepsy syndrome	2.93e-06	5.89e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.92e-06	5.86e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.92e-06	5.86e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTGS2—epilepsy syndrome	2.91e-06	5.83e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.9e-06	5.82e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.89e-06	5.8e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APOE—epilepsy syndrome	2.88e-06	5.79e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.88e-06	5.79e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.88e-06	5.78e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.83e-06	5.69e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.82e-06	5.67e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.82e-06	5.66e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.81e-06	5.64e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.8e-06	5.63e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—epilepsy syndrome	2.78e-06	5.58e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.78e-06	5.57e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.77e-06	5.56e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.74e-06	5.51e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.71e-06	5.45e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—TH—epilepsy syndrome	2.71e-06	5.43e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	2.7e-06	5.43e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.68e-06	5.38e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.66e-06	5.35e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.66e-06	5.34e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.66e-06	5.34e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.65e-06	5.32e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.65e-06	5.31e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.64e-06	5.31e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—TH—epilepsy syndrome	2.64e-06	5.3e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.63e-06	5.29e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.62e-06	5.27e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.61e-06	5.23e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.56e-06	5.14e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.56e-06	5.14e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.52e-06	5.07e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.5e-06	5.03e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.5e-06	5.01e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—TH—epilepsy syndrome	2.49e-06	5e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—POMC—epilepsy syndrome	2.48e-06	4.97e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.48e-06	4.97e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—TH—epilepsy syndrome	2.47e-06	4.95e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—epilepsy syndrome	2.43e-06	4.89e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.43e-06	4.88e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—epilepsy syndrome	2.43e-06	4.87e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—SRC—epilepsy syndrome	2.35e-06	4.72e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	2.31e-06	4.64e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.28e-06	4.59e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.26e-06	4.53e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—epilepsy syndrome	2.26e-06	4.53e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.24e-06	4.5e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.23e-06	4.47e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.2e-06	4.42e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CAT—epilepsy syndrome	2.17e-06	4.37e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.17e-06	4.35e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.12e-06	4.26e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.09e-06	4.19e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.08e-06	4.17e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.06e-06	4.13e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.05e-06	4.11e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.03e-06	4.09e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.03e-06	4.08e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.02e-06	4.06e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.01e-06	4.05e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.99e-06	4e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.98e-06	3.97e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	3.97e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.97e-06	3.95e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.92e-06	3.86e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.85e-06	3.72e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.84e-06	3.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.83e-06	3.66e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.77e-06	3.55e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.75e-06	3.52e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.74e-06	3.49e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.73e-06	3.48e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.73e-06	3.47e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AGT—epilepsy syndrome	1.72e-06	3.46e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOE—epilepsy syndrome	1.69e-06	3.39e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.65e-06	3.31e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.63e-06	3.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TH—epilepsy syndrome	1.63e-06	3.27e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.62e-06	3.26e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.61e-06	3.23e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.59e-06	3.2e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.58e-06	3.17e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	3.08e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.49e-06	2.99e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—epilepsy syndrome	1.46e-06	2.93e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—POMC—epilepsy syndrome	1.45e-06	2.91e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.37e-06	2.75e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.36e-06	2.73e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.36e-06	2.73e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.36e-06	2.72e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.36e-06	2.72e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.34e-06	2.69e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—epilepsy syndrome	1.32e-06	2.66e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.3e-06	2.62e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.25e-06	2.5e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.24e-06	2.48e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—epilepsy syndrome	1.22e-06	2.46e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.21e-06	2.43e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.19e-06	2.38e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.16e-06	2.33e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.16e-06	2.32e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	2.19e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	2.17e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.07e-06	2.14e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.06e-06	2.13e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.04e-06	2.09e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—epilepsy syndrome	9.93e-07	1.99e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.94e-07	1.8e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—epilepsy syndrome	8.15e-07	1.64e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—epilepsy syndrome	7.71e-07	1.55e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	7.13e-07	1.43e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—epilepsy syndrome	5.96e-07	1.2e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.82e-07	1.17e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.48e-07	1.1e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.43e-07	1.09e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.58e-07	7.2e-06	CbGpPWpGaD
